Ken Griffin’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-502
Closed -$11.2K – 15554
2026
Q2
$11.2K Buy
502
+146
+41% +$2.58K ﹤0.01% 13486
2026
Q1
$8.18K Buy
+356
New +$18.6K ﹤0.01% 12781
2025
Q3
– Sell
-822
Closed -$123K – 14472
2025
Q2
$123K Buy
+822
New +$164K ﹤0.01% 11143

Other funds holding MDCX

Ken Griffin's MDCX Position: Q3 2026 in Review

Ken Griffin sold out of Medicus Pharma (MDCX) in Q3 2026, closing a stake of 502 shares — an estimated $11.2K sold.

Ken Griffin first reported a position in MDCX in Q2 2025 and held it in 3 quarters. The position peaked at $123K in Q2 2025. 26 funds tracked by Wall St. Rank hold MDCX as of Q3 2026.

  • Ken Griffin reported no remaining Medicus Pharma position as of Q3 2026 after selling out during the quarter.
  • Ken Griffin sold 502 Medicus Pharma shares in Q3 2026, an estimated $11.2K.
  • Ken Griffin first reported a position in Medicus Pharma in Q2 2025 and held it in 3 quarters.
  • Ken Griffin's Medicus Pharma position peaked at $123K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.